Despite the promotion of the use of telehealth services, access barriers to insulin, other diabetic therapeutics, and diabetic supplies in the outpatient setting may still exist, resulting in poor hemoglobin A1c control for patients with type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.